No Prescription

Alpha Index R

No Prescription » Products » Alpha Index R

List of Drugs:

A  B  C  D  E  F  G  H  I  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Z  #

Products R:

RABICIP Aciphex

RALISTA Evista

RANITIDINE Generic Zantac

Ranolaz Ranexa

RAPACAN Rapamune

Rapamune Generic Sirolimus

Rasalect Azilect

Rasilez Tekturna

RASTINON Orinase

RAZEL Crestor

Rcifax Xifaxan

R CIN Rifadin

Rebose Prebose

REBOXXIN Edronax

RECLIDE Vivazide

Refzil O Cefzil

REGLAN Clopra

Reglan (Metoclopramide)

Relestat Eye Drops Elestat

Remeron (Mirtazapine)

Reminyl Razadyne

Remoxil Amoxil

RENEDIL Plendil

Renitec Vasotec

RENODAPT Cellcept

Requip Generic Ropinirole

Restasis Eye Drops Generic Cyclosporine

Retin A Avita

Retin-A (Tretinoin)

RETINO A Avita

Retino A Cream Retin A

Retrovir (Zidovudine)

Revia (Naltrexone)

REVIBRA Celebrex

REVOCON Nitoman

REZULT Avandia

Rheumacin Indocin

Rheumacin SR Indocin

Rhinocort AqNasal Spray Rhinocort Aqua

RIBAVIN ribavirin

Rifadin (Rifampin)

RIMOSLIM Acomplia

Riomont Acomplia

Risofos Actonel

Risperdal Generic Risperidone

Risperdal (Risperidone)

Ritomune Norvir

Rivamer Exelon

Rizact Maxalt

Robinax Robaxin

ROCALTROL Generic Calcitriol

Rocephin IM Ceftriaxone Sodium Injection

Roliten Detrol

ROPARK Requip

Rosicon G Avandaryl

Rosiglitazone Avandia

Rosuvatin Crestor

ROTAHALER Rotacap Dispenser

ROZUCOR Crestor

Rulide (Roxithromycin)

Previous  Next

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.